Skip to content
healthcare.dev

Veklury

NDC 61958-2901, remdesivir, injection, powder, lyophilized, for solution, from Gilead Sciences, Inc..

Product NDC
61958-2901
Status
Listed
Labeler
Gilead Sciences, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA214787
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61958-2901 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • REMDESIVIR100 mg/1

Pharmacologic classes

SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]

Package NDCNDC-11Package
61958-2901-2619582901021 VIAL, SINGLE-DOSE in 1 CARTON (61958-2901-2) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c0978fa8-53ff-4ca2-82a7-567fd3e958ca
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=61958-2901

Use it

Look up 61958-2901 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61958-2901 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61958-2901. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.